Emory H. and Mizrahi, N, 2016, Glycaemic Control By Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes.  Journal of Diabetes & Vascular Research Disease.   DOI: 10.1177/1479164116675492
Emory H. and Mizrahi, N, 2016, Monoamine Oxidase Inhibition in a Patient With Type I Diabetes and Depression. Journal of Diabetes Science and Technology. DOI: 10.1177/1932296816638106
Emory WH, Wells C, and Mizrahi N. Quantitative EEG and Current Source
Density Analysis of Combined Antiepileptic Drugs and
Dopaminergic Agents in Genetic Epilepsy: Two Case Studies. Clin EEG
Neurosc. 2015; 46(3): 256-262. doi: 10.1177/1550059414532253
Suffin S.C., Emory W.H., Gutierrez G, Arora G, Schiller M.J., Kling A.  A QEEG database method for predicting pharmacotherapeutic outcome in refractory major depressive disorders.  Journal of American Physicians and Surgeons 2007:12 (4):104-8.
Schiller, M.J., Emory, W.H., Suffin, S.C., 2004. rEEG – in the treatment of eating disorder. Poster, NCDEU Conference. 
Suffin S.C. and Emory W.H.. 1995. Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic Outcome. Clin EEG Neurosc; 26(2).